We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA and EMA Collaborate on Expandable Model for Rare Pediatric Drug Development
FDA and EMA Collaborate on Expandable Model for Rare Pediatric Drug Development
The FDA and the European Medicines Agency released a draft joint plan this month to support the development of pediatric treatments for Gaucher disease — an approach the agencies say can apply to rare diseases in general.
